Sound Income Strategies LLC Grows Holdings in Sabra Healthcare REIT, Inc. $SBRA

Sound Income Strategies LLC boosted its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report) by 5.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 918,252 shares of the real estate investment trust’s stock after buying an additional 49,144 shares during the quarter. Sound Income Strategies LLC’s holdings in Sabra Healthcare REIT were worth $17,897,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in SBRA. Principal Financial Group Inc. grew its stake in shares of Sabra Healthcare REIT by 21.6% during the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after acquiring an additional 4,431,897 shares in the last quarter. Lasalle Investment Management Securities LLC acquired a new position in shares of Sabra Healthcare REIT in the fourth quarter worth about $66,938,000. Norges Bank acquired a new position in shares of Sabra Healthcare REIT in the fourth quarter worth about $57,945,000. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Sabra Healthcare REIT by 1,019.8% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock valued at $56,922,000 after purchasing an additional 2,736,993 shares during the last quarter. Finally, Balyasny Asset Management L.P. purchased a new position in Sabra Healthcare REIT in the second quarter valued at about $49,955,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently commented on SBRA shares. UBS Group set a $19.00 target price on Sabra Healthcare REIT in a research note on Thursday, June 18th. Cantor Fitzgerald lifted their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. Wells Fargo & Company upped their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a report on Monday, June 1st. Weiss Ratings downgraded shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research note on Thursday, June 4th. Finally, Truist Financial increased their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research note on Friday, March 13th. Four investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Sabra Healthcare REIT presently has an average rating of “Hold” and an average target price of $21.30.

Read Our Latest Research Report on Sabra Healthcare REIT

Sabra Healthcare REIT Stock Up 2.4%

Shares of Sabra Healthcare REIT stock opened at $20.16 on Friday. The business has a 50-day moving average price of $19.70 and a 200 day moving average price of $19.66. Sabra Healthcare REIT, Inc. has a fifty-two week low of $17.17 and a fifty-two week high of $21.28. The firm has a market cap of $5.08 billion, a P/E ratio of 32.00, a P/E/G ratio of 1.47 and a beta of 0.65. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRAGet Free Report) last released its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. The company had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.Sabra Healthcare REIT’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is currently 190.48%.

Sabra Healthcare REIT Profile

(Free Report)

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

See Also

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRAFree Report).

Institutional Ownership by Quarter for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.